Research progress on the outcome of hypersplenism after liver transplantation for liver cirrhosis
10.3760/cma.j.cn113884-20210706-00221
- VernacularTitle:肝硬化肝移植术后脾功能亢进转归的研究进展
- Author:
Mengxiu HUANG
1
;
Jing WANG
;
Shaocheng LYU
;
Tao JIANG
;
Fei PAN
;
Qiang HE
;
Ren LANG
Author Information
1. 首都医科大学附属北京朝阳医院肝胆外科，北京 100020
- Keywords:
Hypersplenism;
Liver cirrhosis;
Liver transplantation;
Intractable hypersplenism
- From:
Chinese Journal of Hepatobiliary Surgery
2021;27(12):957-960
- CountryChina
- Language:Chinese
-
Abstract:
Hypersplenism is the most common splenic disease and usually refers to a clinical syndrome of increased splenic size and/or cytopenia due to various causes. Hypersplenism is most often secondary to cirrhotic hypertension. Liver transplantation can effectively relieve hypersplenism in patients with liver cirrhosis, but there are also some patients with persistent hypersplenism after liver transplantation or recurrence after remission. Other treatment modalities for postoperative intractable hypersplenism include splenectomy and partial splenic artery embolization. This article reviews the research progress of hypersplenism after liver transplantation for liver cirrhosis with hypersplenism.
